Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of Abiraterone Acetate Tablets USP, 250 mg, a generic version of Johnson & Johnson’s (NYSE:JNJ) Zytiga.
The Zytiga brand and generic market had U.S. sales of ~$454M for the year ended March 2020 according to IQVIA Health.
https://seekingalpha.com/news/3584444-dr-reddys-launches-generic-abiraterone-acetate-tablets-in-u-s
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.